Literature DB >> 11510294

A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.

K Wieczorowska-Tobis1, A Polubinska, A Breborowicz, D G Oreopoulos.   

Abstract

Phosphate-buffered saline (PBS), an isotonic solution with a physiologic pH can be considered an example of a biocompatible dialysis fluid. This study compared the biocompatibility of PBS with that of Dianeal 3.86% (Baxter Healthcare Corporation, Deerfield, IL, U.S.A.), using a model of peritoneal dialysis in the rat. In an acute experiment, after catheter implantation, rats were infused on day 1 with PBS, on day 5 with standard dialysis solution (Dianeal 3.86%), and on day 7 again with PBS. When rats were injected with Dianeal 3.86%, the inflammatory reaction was suppressed as compared with PBS. The cell count was lower with Dianeal (-85%, p < 0.001), the neutrophil:macrophage ratio in dialysate was 80% lower (p < 0.01), total protein concentration in the Dianeal dialysate was 73% lower (p < 0.01), and the dialysate nitrite level was 45% lower (p < 0.01). In a chronic experiment, after catheter implantation, rats were dialyzed for four weeks with PBS or with Dianeal 3.86%. At the end of the study, a 1-hour peritoneal equilibration test (PET) was performed. As evaluated on a semiquantitative scale, macroscopic changes in the peritoneum were more severe in rats exposed to PBS than in those exposed to Dianeal 3.86% (8.6 +/- 3.2 vs 5.2 +/- 2.6, p < 0.05). The thickness of the visceral peritoneum was comparable in both groups; but, in PBS-treated rats, the peritoneal interstitium contained more inflammatory cells and more new vessels. During the 1-hour PET, peritoneal permeability to water and solutes was comparable in the two groups. Despite a more physiologic composition, PBS is a less biocompatible peritoneal dialysis solutions than is standard, acidic, hypertonic dialysis solution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11510294

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  5 in total

1.  Chronic infusion of sterile peritoneal dialysis solution abrogates enhanced peritoneal gene expression responses to chronic peritoneal catheter presence.

Authors:  El Rasheid Zakaria; Paul J Matheson; Ryan T Hurt; Richard N Garrison
Journal:  Adv Perit Dial       Date:  2008

2.  Neuropeptide release augments serum albumin loss and reduces ultrafiltration in peritoneal dialysis.

Authors:  Nicola Cavallini; Dick Delbro; Gunnar Tobin; Magnus Braide
Journal:  Perit Dial Int       Date:  2011-09-30       Impact factor: 1.756

3.  A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.

Authors:  Fan Lin; Xu Wu; Huidi Zhang; Xiaohan You; Zhoucang Zhang; Rongrong Shao; Chaoxing Huang
Journal:  BMC Nephrol       Date:  2015-04-09       Impact factor: 2.388

4.  Experimental Conditions That Influence the Utility of 2'7'-Dichlorodihydrofluorescein Diacetate (DCFH2-DA) as a Fluorogenic Biosensor for Mitochondrial Redox Status.

Authors:  Lianne R de Haan; Megan J Reiniers; Laurens F Reeskamp; Ali Belkouz; Lei Ao; Shuqun Cheng; Baoyue Ding; Rowan F van Golen; Michal Heger
Journal:  Antioxidants (Basel)       Date:  2022-07-22

Review 5.  Animal Models of Peritoneal Dialysis: Thirty Years of Our Own Experience.

Authors:  Krzysztof Pawlaczyk; Ewa Baum; Krzysztof Schwermer; Krzysztof Hoppe; Bengt Lindholm; Andrzej Breborowicz
Journal:  Biomed Res Int       Date:  2015-07-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.